Invests in fixed-income securities of U.S. and foreign corporate issuers. Focuses on corporate bonds, collateralized loan obligations, and mortgage-backed securities. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 9% a year over the last 4 years. Red columns mark years that ended in a loss.
This company is not turning a profit, so the market is pricing its sales instead: 8.6× for every dollar of annual revenue.
No analyst target is on record for this company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
Over the last 4 years, sales grew about 9% a year on average.
Sales run at $56.1M a year. A small number, but proof the product has real buyers.
It pays out $0.58 per share each year — regular cash for whoever holds the stock.
A loss of $25.7M against $56.1M in annual sales. And on top of that, sales fell from the year before.
The price action doesn’t yet back an upward turn. Council score: 0/10.
Costs swallow the gains that sales growth brings in. Council score: 4/10.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.